Kids with IBD may get their infusion time cut in half without extra risk
NCT ID NCT06839820
First seen Apr 28, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study looks at whether giving infliximab over 30 minutes is as safe as the usual 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 children aged 1 to 17 who have already had at least 5 infliximab infusions will receive 8 infusions, alternating between 30-minute and 60-minute rates. The goal is to see if the faster rate causes just as few infusion reactions and improves satisfaction for patients and nurses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENT SATISFACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, 1478, Norway
Conditions
Explore the condition pages connected to this study.